- LAVAL, Quebec—Bausch Health Companies Inc. (NYSE/TSX: BHC) this morning announced a plan to spin off its leading Bausch + Lomb eye health business into an independent publicly traded entity separate from the remainder of Bausch Health. The spinoff will establish two separate companies, including a fully integrated, pure play eye-health company built on the iconic Bausch + Lomb brand and long history of innovation. The remaining Bausch Health company would be a diversified pharmaceutical company with leading positions in gastroenterology, aesthetics/dermatology, neurology and international pharmaceuticals, according to Thursday’s announcement.
- SAN RAMON, Calif.—CooperVision on Monday announced the appointment of Rajeev Garg, PhD, as global head of myopia management strategy. In this newly created role, he leads various myopia-related initiatives, including market development, acquisitions and joint ventures, technology licensing, and lifecycle management in this growing segment of vision care. Garg brings more than 20 years of experience in driving innovation and growth in health care, including optometry and ophthalmology. He most recently served as executive director, surgical marketing at Bausch + Lomb, and previously held senior marketing roles within Johnson & Johnson’s cataract, contact lens and sterilization businesses. Earlier in his career, he focused on pharmaceutical development at Abbott and Merck.
- JACKSONVILLE, Fla. – Johnson & Johnson Vision has received the FDA’s “breakthrough device” designation for its myopia control lens, company executives noted on a recent conference call with securities analysts following the announcement of second-quarter financial results. Chris DelOrefice, Johnson & Johnson’s vice president for investor relations, noted the FDA’s action on the company’s myopia lens on the July 16 conference call.
Citing Negative Impact of COVID-19, Johnson & Johnson Reports That Second-Quarter Sales Declined 10.8 PercentNEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) noted Thursday the negative impact of COVID-19 when it reported second-quarter results showing a sales decline of 10.8 percent (a decline of 9 percent on an operational basis) on a company-wide basis.
- ALEXANDRIA, Va.—The Health Care Alliance for Patient Safety (APS) said Wednesday the U.S. House's Committee on Appropriations is moving to delay the effective date and enforcement of the amendments in the recently finalized Contact Lens Rule. The Federal Trade Commission (FTC) released its updated CL rule late last month, as VMAIL reported. A number of other companies and optical organizations, including the American Optometric Association, also have publicly declared their opposition to the FTC's updated CL rule, as VMAIL reported.
- WATERLOO, Ontario—For the first time, the premier searchable contact lens database for eyecare practitioners (ECPs)—the Contact Lens Compendium—is accessible in the U.S. With the launch of the U.S. version, ECPs now have free access to the most up-to-date listing of contact lens products.
Bausch + Lomb to Expand Lens Manufacturing and Distribution Facility in Lynchburg, Va., Governor AnnouncesRICHMOND—Virginia Gov. Ralph Northam announced last week that Bausch + Lomb, a division of Bausch Health Companies Inc. (NYSE/TSX: BHC), will invest more than $35 million to expand its manufacturing facility in the city of Lynchburg.
- SAN RAMON, Calif.—A second CooperVision contact lens manufacturing facility has earned prestigious LEED Silver certification for its environmentally conscious design and operation, the company announced recently. Opened in 1999, the 540,000-square-foot site in Juana Díaz, Puerto Rico, produces the company’s popular silicone hydrogel contact lenses including, MyDay and Biofinity brands. CooperVision’s clariti 1 day production site in Alajuela, Costa Rica, earned its LEED Silver certification in late 2018, as VMAIL reported.
- ALEXANDRIA, Va.—The Health Care Alliance for Patient Safety (APS) on Tuesday raised concerns about the final Federal Trade Commission (FTC) Contact Lens Rule, which was issued last week, as VMAIL reported. The Alliance, in its statement, said the FTC’s final contact lens rule “fails to adequately address the dangerous practice of utilizing computer-generated voice calls to verify contact lens prescriptions and places significant burdens on doctors,” among other shortcomings cited by the Alliance for Patient Safety.